Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.

@article{Lunn2012ImmunotherapyFI,
  title={Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.},
  author={Michael P T Lunn and Eduardo Nobile-Orazio},
  journal={The Cochrane database of systematic reviews},
  year={2012},
  volume={5},
  pages={CD002827}
}
BACKGROUND Serum monoclonal anti-myelin-associated glycoprotein antibodies may be pathogenic in some people with immunoglobulin M (IgM) paraprotein and demyelinating neuropathy. Immunotherapies aimed at reducing the level of these antibodies might be expected to be beneficial. This is an update of a review first published in 2003 and previously updated in 2006. OBJECTIVES To assess the effects of immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated demyelinating… CONTINUE READING
52 Extracted Citations
24 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 52 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 24 references

New ’Risk of bias’ methodology was included

  • Searches were updated to June
  • this update, data were extracted independently…
  • 2011
Highly Influential
5 Excerpts

Quantitating overall neuropathic symptoms, impairments and outcomes

  • PJ Dyck 2005 Dyck, RAC Hughes, PC. O’Brien
  • 2005

Improvement of sensory ataxia in anti-MAG antibody associated polyneuropathy with interferon alpha: A posturographic study

  • J Pouget 2000 Pouget, JPH Azulay, S Mesure, S. Attarian
  • Neurology
  • 2000

Long-term prognosis of neuropathy associated with antiMAG IgM M-proteins and its relationship to immune therapies

  • N Meucci, L Baldini, A Di Troia, G. Scarlato
  • Nobile-Orazio
  • 2000

Similar Papers

Loading similar papers…